SIRT2 and myeloid sarcoma: The sirtuin family, including SIRT2 (NAD-dependent protein deacetylase sirtuin-2) has been implicated in neurodegenerative processes (Lu et al., 2023), which may have relevance in MS (Foolad et al., 2019).